BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 24919708)

  • 1. Radiation exposure of patients undergoing whole-body FDG-PET/CT examinations: an update pursuant to the new ICRP recommendations.
    Brix G; Nosske D; Lechel U
    Nuklearmedizin; 2014; 53(5):217-20. PubMed ID: 24919708
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radiation exposure of patients undergoing whole-body dual-modality 18F-FDG PET/CT examinations.
    Brix G; Lechel U; Glatting G; Ziegler SI; Münzing W; Müller SP; Beyer T
    J Nucl Med; 2005 Apr; 46(4):608-13. PubMed ID: 15809483
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ionising radiation-free whole-body MRI versus (18)F-fluorodeoxyglucose PET/CT scans for children and young adults with cancer: a prospective, non-randomised, single-centre study.
    Klenk C; Gawande R; Uslu L; Khurana A; Qiu D; Quon A; Donig J; Rosenberg J; Luna-Fineman S; Moseley M; Daldrup-Link HE
    Lancet Oncol; 2014 Mar; 15(3):275-85. PubMed ID: 24559803
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estimation of patient dose in (18)F-FDG and (18)F-FDOPA PET/CT examinations.
    Kaushik A; Jaimini A; Tripathi M; D'Souza M; Sharma R; Mishra AK; Mondal A; Dwarakanath BS
    J Cancer Res Ther; 2013; 9(3):477-83. PubMed ID: 24125986
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Standardized uptake values for [¹⁸F] FDG in normal organ tissues: comparison of whole-body PET/CT and PET/MRI.
    Heusch P; Buchbender C; Beiderwellen K; Nensa F; Hartung-Knemeyer V; Lauenstein TC; Bockisch A; Forsting M; Antoch G; Heusner TA
    Eur J Radiol; 2013 May; 82(5):870-6. PubMed ID: 23394765
    [TBL] [Abstract][Full Text] [Related]  

  • 6. JOURNAL CLUB: CT dose optimization for whole-body PET/CT examinations.
    Tonkopi E; Ross AA; MacDonald A
    AJR Am J Roentgenol; 2013 Aug; 201(2):257-63. PubMed ID: 23883207
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Technologist radiation exposure in routine clinical practice with 18F-FDG PET.
    Guillet B; Quentin P; Waultier S; Bourrelly M; Pisano P; Mundler O
    J Nucl Med Technol; 2005 Sep; 33(3):175-9. PubMed ID: 16145226
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Variation of system performance, quality control standards and adherence to international FDG-PET/CT imaging guidelines. A national survey of PET/CT operations in Austria.
    Rausch I; Bergmann H; Geist B; Schaffarich M; Hirtl A; Hacker M; Beyer T
    Nuklearmedizin; 2014; 53(6):242-8. PubMed ID: 25131649
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radiation exposure of patients and personnel from a PET/CT procedure with 18F-FDG.
    Leide-Svegborn S
    Radiat Prot Dosimetry; 2010; 139(1-3):208-13. PubMed ID: 20167792
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methods of CT Dose Estimation in Whole-Body ¹⁸F-FDG PET/CT.
    Inoue Y; Nagahara K; Tanaka Y; Miyatake H; Hata H; Hara T
    J Nucl Med; 2015 May; 56(5):695-700. PubMed ID: 25840979
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A retrospective evaluation of radiation dose associated with low dose FDG protocols in whole-body PET/CT.
    Willowson KP; Bailey EA; Bailey DL
    Australas Phys Eng Sci Med; 2012 Mar; 35(1):49-53. PubMed ID: 22160927
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radiation Dosimetry of Whole-Body Dual-Tracer 18F-FDG and 11C-Acetate PET/CT for Hepatocellular Carcinoma.
    Liu D; Khong PL; Gao Y; Mahmood U; Quinn B; St Germain J; Xu XG; Dauer LT
    J Nucl Med; 2016 Jun; 57(6):907-12. PubMed ID: 26823568
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical role of 18F-FDG PET/CT in the management of squamous cell carcinoma of the head and neck and thyroid carcinoma.
    Quon A; Fischbein NJ; McDougall IR; Le QT; Loo BW; Pinto H; Kaplan MJ
    J Nucl Med; 2007 Jan; 48 Suppl 1():58S-67S. PubMed ID: 17204721
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radiation dosimetry of 18F-FDG PET/CT: incorporating exam-specific parameters in dose estimates.
    Quinn B; Dauer Z; Pandit-Taskar N; Schoder H; Dauer LT
    BMC Med Imaging; 2016 Jun; 16(1):41. PubMed ID: 27317478
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Whole-body 18F-FDG PET/CT: the need for a standardized field of view--a referring-physician aid.
    Huston SF; Abdelmalik AG; Nguyen NC; Farghaly HR; Osman MM
    J Nucl Med Technol; 2010 Sep; 38(3):123-7. PubMed ID: 20724533
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The determination of patient dose from (18)F-FDG PET/CT examination.
    Khamwan K; Krisanachinda A; Pasawang P
    Radiat Prot Dosimetry; 2010 Sep; 141(1):50-5. PubMed ID: 20400773
    [TBL] [Abstract][Full Text] [Related]  

  • 17. National survey of patient doses from whole-body FDG PET-CT examinations in France in 2011.
    Etard C; Celier D; Roch P; Aubert B
    Radiat Prot Dosimetry; 2012 Dec; 152(4):334-8. PubMed ID: 22586156
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Whole-body PET/CT studies with lowered ¹⁸F-FDG doses: the influence of body mass index in dose reduction.
    Sánchez-Jurado R; Devis M; Sanz R; Aguilar JE; del Puig Cózar M; Ferrer-Rebolleda J
    J Nucl Med Technol; 2014 Mar; 42(1):62-7. PubMed ID: 24503348
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An Australian local diagnostic reference level for paediatric whole-body
    Alkhybari EM; McEntee MF; Willowson KP; Brennan PC; Kitsos T; Kench PL
    Br J Radiol; 2019 Apr; 92(1096):20180879. PubMed ID: 30653334
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Operational radiation safety for PET-CT, SPECT-CT, and cyclotron facilities.
    Zanzonico P; Dauer L; St Germain J
    Health Phys; 2008 Nov; 95(5):554-70. PubMed ID: 18849690
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.